Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Axsome Therapeutics stock | $40.1

Learn how to easily invest in Axsome Therapeutics stock.

Axsome Therapeutics Inc is a biotechnology business based in the US. Axsome Therapeutics shares (AXSM) are listed on the NASDAQ and all prices are listed in US Dollars. Axsome Therapeutics employs 93 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Axsome Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AXSM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Axsome Therapeutics stock price (NASDAQ: AXSM)

Use our graph to track the performance of AXSM stocks over time.

Axsome Therapeutics shares at a glance

Information last updated 2021-10-16.
Latest market close$40.10
52-week range$19.38 - $87.24
50-day moving average $30.88
200-day moving average $48.38
Wall St. target price$86.21
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.04

Buy Axsome Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Axsome Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Axsome Therapeutics price performance over time

Historical closes compared with the close of $40.1 from 2021-10-15

1 week (2021-10-07) 26.34%
1 month (2021-09-17) 34.93%
3 months (2021-07-16) -26.04%
6 months (2021-04-16) -24.96%
1 year (2020-10-16) -45.62%
2 years (2019-10-18) 90.59%
3 years (2018-10-18) 878.05%
5 years (2016-10-18) 446.32%

Axsome Therapeutics financials

Gross profit TTM $0
Return on assets TTM -40.21%
Return on equity TTM -100.7%
Profit margin 0%
Book value $1.90
Market capitalisation $1.5 billion

TTM: trailing 12 months

Shorting Axsome Therapeutics shares

There are currently 3.8 million Axsome Therapeutics shares held short by investors – that's known as Axsome Therapeutics's "short interest". This figure is 12.6% up from 3.4 million last month.

There are a few different ways that this level of interest in shorting Axsome Therapeutics shares can be evaluated.

Axsome Therapeutics's "short interest ratio" (SIR)

Axsome Therapeutics's "short interest ratio" (SIR) is the quantity of Axsome Therapeutics shares currently shorted divided by the average quantity of Axsome Therapeutics shares traded daily (recently around 1.1 million). Axsome Therapeutics's SIR currently stands at 3.37. In other words for every 100,000 Axsome Therapeutics shares traded daily on the market, roughly 3370 shares are currently held short.

However Axsome Therapeutics's short interest can also be evaluated against the total number of Axsome Therapeutics shares, or, against the total number of tradable Axsome Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Axsome Therapeutics's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Axsome Therapeutics shares in existence, roughly 100 shares are currently held short) or 0.1275% of the tradable shares (for every 100,000 tradable Axsome Therapeutics shares, roughly 128 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Axsome Therapeutics.

Find out more about how you can short Axsome Therapeutics stock.

Axsome Therapeutics share dividends

We're not expecting Axsome Therapeutics to pay a dividend over the next 12 months.

Axsome Therapeutics share price volatility

Over the last 12 months, Axsome Therapeutics's shares have ranged in value from as little as $19.38 up to $87.24. A popular way to gauge a stock's volatility is its "beta".

AXSM.US volatility(beta: 2.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axsome Therapeutics's is 2.2265. This would suggest that Axsome Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Axsome Therapeutics overview

Axsome Therapeutics, Inc. , a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial for the treatment of Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. The company is also developing AXS-07 for the treatment of migraine; AXS-12 for the treatment of narcolepsy; and AXS-14 for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Frequently asked questions

What percentage of Axsome Therapeutics is owned by insiders or institutions?
Currently 21.404% of Axsome Therapeutics shares are held by insiders and 61.426% by institutions.
How many people work for Axsome Therapeutics?
Latest data suggests 93 work at Axsome Therapeutics.
When does the fiscal year end for Axsome Therapeutics?
Axsome Therapeutics's fiscal year ends in December.
Where is Axsome Therapeutics based?
Axsome Therapeutics's address is: 22 Cortlandt Street, New York, NY, United States, 10007
What is Axsome Therapeutics's ISIN number?
Axsome Therapeutics's international securities identification number is: US05464T1043
What is Axsome Therapeutics's CUSIP number?
Axsome Therapeutics's Committee on Uniform Securities Identification Procedures number is: 05464T104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site